198 related articles for article (PubMed ID: 19715595)
1. Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion.
Masola V; Maran C; Tassone E; Zin A; Rosolen A; Onisto M
BMC Cancer; 2009 Aug; 9():304. PubMed ID: 19715595
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
3. Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis.
Tang WQ; Hei Y; Lin J
Int J Ophthalmol; 2022; 15(1):31-39. PubMed ID: 35047353
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
5. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
9. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
[TBL] [Abstract][Full Text] [Related]
10. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.
Armeanu-Ebinger S; Bonin M; Häbig K; Poremba C; Koscielniak E; Godzinski J; Warmann SW; Fuchs J; Seitz G
Int J Oncol; 2011 Apr; 38(4):993-1000. PubMed ID: 21271214
[TBL] [Abstract][Full Text] [Related]
12. NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Romualdi C; Bisogno G; Lanfranchi G
Oncotarget; 2017 May; 8(20):33086-33099. PubMed ID: 28380437
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
[TBL] [Abstract][Full Text] [Related]
14. Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells.
Chen J; Zheng D; Shen J; Ruan J; Li A; Li W; Xie G; Luo X; Zhao P; Zheng H
Oncol Rep; 2013 May; 29(5):1888-94. PubMed ID: 23467769
[TBL] [Abstract][Full Text] [Related]
15. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
Allen-Rhoades W; Lupo PJ; Scheurer ME; Chi YY; Kuttesch JF; Venkatramani R; Meyer WH; Mascarenhas L
Cancer Med; 2023 May; 12(9):10222-10229. PubMed ID: 37016270
[TBL] [Abstract][Full Text] [Related]
16. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.
Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956
[TBL] [Abstract][Full Text] [Related]
17. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma.
Oda Y; Kohashi K; Yamamoto H; Tamiya S; Kohno K; Kuwano M; Iwamoto Y; Tajiri T; Taguchi T; Tsuneyoshi M
Cancer Sci; 2008 Apr; 99(4):726-32. PubMed ID: 18377424
[TBL] [Abstract][Full Text] [Related]
18. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
[TBL] [Abstract][Full Text] [Related]
19. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
[TBL] [Abstract][Full Text] [Related]
20. Interleukin‑17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer.
Lv Q; Wu K; Liu F; Wu W; Chen Y; Zhang W
Int J Oncol; 2018 Oct; 53(4):1809-1817. PubMed ID: 30066843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
